Medical Device and Diagnostic Industry (MD+DI)

Dexcom CEO Talks G8 CGM Sensor

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...
FierceBiotech

Dexcom adds upgraded One+ glucose monitoring system to European slate

In 2022, Dexcom began rolling out in Europe the Dexcom One system, a straightforward continuous glucose monitoring setup that stripped away some of the bells and whistles of its flagship G-series CGMs ...
Drug Delivery Business

New Dexcom CEO Jake Leach talks 2026 roadmap, next-gen tech

In July, Leach was tapped to take the CEO role permanently at the start of 2026 as part of Dexcom’s planned succession ...
FierceBiotech

Dexcom's next-gen G7 diabetes sensor scores European approval

Dexcom has obtained European approval for the latest generation of its wearable diabetes sensor, the G7 continuous glucose monitor, for adults and children ages two and up. Designed to be 60% smaller ...
Nasdaq

Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes

LONDON--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM ...
Nasdaq

DexCom (DXCM) Launches Latest CGM Sensor ONE in France

DexCom, Inc. DXCM announced that its DexCom ONE continuous glucose monitoring (CGM) system has been launched in France for people with diabetes. The latest CGM sensor from the company’s portfolio has ...